ライフサイエンスコーパス: kg

1 percent change, -28.0) at 6 years, and -35.0 kg (95% CI, -38.4 to -31.7; mean percent change, -26.9)

2 d class II and III (severe) obesity (>/=35.0 kg/m(2)).

3 1 kg/m(2)] vs 29.8 kg/m(2) [range, 22.9-44.0 kg/m(2)]) were not significantly different.

4 n body weight in the surgery group was -45.0 kg (95% confidence interval [CI], -47.2 to -42.9; mean p

5 ange at 12 years in nonsurgery group 2 was 0 kg (95% CI, -3.5 to 3.5; mean percent change, -0.9).

6 was found that the chlorpyrifos was 0.018mg/kg, which is above maximum residue limits (0.01mg/kg), w

7 hich is above maximum residue limits (0.01mg/kg), which might be toxic to body.

8 e limit of quantification (12.53-19.01microg.kg(-1)) but below the maximum residue limit (100microg.k

9 of oregano extract (13.32, 17.79 and 24.01mL/kg), based on antioxidant capacity determined using the

10 OB, diabetic individuals lost a mean of 2.04 kg (95% CI: -0.20, 4.28 kg; P = 0.07) more on the high-f

11 groups, respectively (mean difference: -1.06 kg; 95% CI: -2.75, 0.63 kg; P = 0.22).

12 runk lean mass found in 2RDA (+1.39 +/- 1.09 kg, P < 0.001).

13 lesser than or equal to LB/UB 0.5/1.0microg.kg(-1) in all samples, except in fish samples (mean LB/U

14 eight reduction with tolvaptan (-2.4 +/- 2.1 kg vs. -0.9 +/- 1.8 kg; p < 0.001).

15 y mass index of 27.8 kg/m(2) (IQR, 26.0-33.1 kg/m(2)).

16 y mass index (31.4 kg/m(2) [range, 24.7-48.1 kg/m(2)] vs 29.8 kg/m(2) [range, 22.9-44.0 kg/m(2)]) wer

17 ng temperatures decreased yields by 0.8% (10 kg/ha) per degrees C.

18 A 10-kg achieved weight loss after 1 year was related to a ha

19 lic syndrome (MeS), were administered 1000mg/kg of flavanol enriched grape seed polyphenol extract (G

20 itted Regulatory limits of 500 or 1000microg.kg(-1) in fishery products and muscle meat of fish.

21 t below the maximum residue limit (100microg.kg(-1)).

22 m in diameter were in the range of 1041-1063 kg m(-3) with standard deviations of 0.6-1.1%.

23 ttable disease, or who weighed more than 125 kg.

24 kg for DON, 24microg/kg for ZEA and 12microg/kg for T-2 toxin.

25 ructed with a PVC membrane containing 12mmol/kg of the polyamine bisnaphthalimidopropyl-4,4'-diaminod

26 gy steadily increased yields by about 1% (13 kg/ha) per year while increasing temperatures decreased

27 -insecurity score was associated with a 0.13-kg lower body weight (P < 0.001) and a 0.26-cm(3) lower

28 bserved at 4 degrees C after 90days (0.14meq/kg and -43.5mV, respectively).

29 ing compared with optimized urea-N rate (150 kg N ha(-1), based on N requirement by target yield of 7

30 osmarinus officinalis L.) (ROSM) (200-1500mg/kg) and ascorbyl palmitate (AP) (100-300mg/kg) were test

31 The limits of detection were 15microg/kg for DON, 24microg/kg for ZEA and 12microg/kg for T-2

32 0.63 vs. 0.37 kg/m(2)/yr), OC (0.28 vs. 0.18 kg/m(2)/yr) and TN (3.7 vs. 6.1 g/m(2)/yr) ever reported

33 , 7 years), weighing 14 to 34 kg (median, 18 kg) kg of whom 4 had occluded inferior vena cava or ilia

34 r unprepared infant cereals (LOQ of 18microg.kg(-1)).

35 to a limit of quantification (LOQ) of 0.1mg/kg.

36 arsenic (i-As), at concentrations around 1mg/kg.

37 e 336.7 kg ha(-1), 8131.8 kg ha(-1) and 24.2 kg kg(-1), respectively.

38 eatohepatitis etiology 24%; BMI 33.3 +/- 3.2 kg/m(2) ; Child A 92%; HVPG >/=10 mm Hg, 72%).

39 Every 2 kg/m(2) increase in BMI above 20 kg/m(2) was associated

40 ere 57.5 (+/- 10.1) years and 36.1 (+/- 6.2) kg/m(2), respectively, and 82% had stage I or II breast

41 Every 2 kg/m(2) increase in BMI above 20 kg/m(2) was associated with a 7.4% (7.1-7.6) increase in

42 e: 1.05 [95% confidence interval, 0.90-1.20] kg/m(2) per 1-U increase, P<0.001) and incident AF (FTO,

43 Sunflower oil with TBHQ (SOTBHQ) (200mg/kg) and without additives (SOcontrol) served as positive

44 The mice could tolerate 20mg/kg PTX formulated in nano-formulations, which doubled th

45 ification limits were lower than 9 and 21mug/kg, respectively.

46 ranging from 2578+/-86mg/kg to 5063+/-230mg/kg of dry weight potato flesh.

47 contained morphine ranging from 0.2 to 240mg/kg.

48 detection were 15microg/kg for DON, 24microg/kg for ZEA and 12microg/kg for T-2 toxin.

49 nder the conditions tested, addition of 24mL/kg of oregano extract could be recommended as a natural

50 0 and BMI was observed between BMI 12 and 25 kg/m(2) (p = 0.007).

51 /= 31 for men and body mass index [BMI] > 25 kg/m(2) ), healthy non-NAFLD controls (normal ALT and BM

52 ompared to larger children and adults (>/=25 kg) after administration of the manufacturers' currently

53 piperaquine exposures in small children (<25 kg) compared to larger children and adults (>/=25 kg) af

54 BMI over 25 kg/m(2), diabetes, past and current smoking, red meat co

55 articipants were aged 6-11 years, weighed 25 kg or more, had virological suppression (<50 copies of H

56 treated samples at an energy input of 256kJ/kg (37.0%, 15.6%, 29.4%, 26.5%, 23.5% for phenolics, ant

57 except in fish samples (mean LB/UB 25microg.kg(-1) with a maximum of 53microg.kg(-1)).

58 rization, with >/=1 LRF (body mass index >27 kg/m(2), self-reported physical inactivity, and/or smoki

59 lost a mean of 2.04 kg (95% CI: -0.20, 4.28 kg; P = 0.07) more on the high-fat and low-carbohydrate

60 </=1, age </=65 years, body mass index 19-29 kg/m).

61 s 22%), higher body mass index (31 versus 29 kg/m(2)), worse Minnesota Living With Heart Failure scor

62 ve forcing of open-water fluxes (3.5 +/- 0.3 kg CO2 -eq m(-2) yr(-1) ) exceeded that of vegetated zon

63 er productivity) was nearly constant for 2.3 kg/m(3).

64 ean percent change, -35.0) at 2 years, -36.3 kg (95% CI, -39.0 to -33.5; mean percent change, -28.0)

65 tern nations, obesity (body mass index >/=30 kg/m(2)) has rapidly increased since the 1970s to become

66 of >/=2, sleep apnea, or body mass index >30 kg/m(2).

67 fined as donor body mass index (D-BMI) of 30 kg/m or greater, has been associated with increased risk

68 ischemia, right kidneys were removed from 30-kg Yorkshire pigs and preserved with 8-hour NEVKP or in

69 With an estimated body mass exceeding 1,300 kg, B. markmitchelli was much larger than modern terrest

70 g/kg) and ascorbyl palmitate (AP) (100-300mg/kg) were tested for 18hopen pan-frying.

71 mercury was not detected (LOD of 0.30microg.kg(-1) fresh weight) in 92.4% of the 291 food samples an

72 7 years (median, 7 years), weighing 14 to 34 kg (median, 18 kg) kg of whom 4 had occluded inferior ve

73 d centennial timescale, of OM (0.63 vs. 0.37 kg/m(2)/yr), OC (0.28 vs. 0.18 kg/m(2)/yr) and TN (3.7 v

74 of the analysed polyphenols ranged from 3mg/kg for dehulled red lentils to 1630.5mg/kg for ruviotto

75 xceeded that of vegetated zones (1.4 +/- 0.4 kg CO2 -eq m(-2) yr(-1) ) due to high ecosystem respirat

76 2-26 years]), and mean body mass index (31.4 kg/m(2) [range, 24.7-48.1 kg/m(2)] vs 29.8 kg/m(2) [rang

77 -0.14, -0.02 mmol/L), and body weight (-1.40 kg; 95% CI: -2.07, -0.74 kg).

78 ormoglycemic individuals lost a mean of 0.43 kg (95% CI: 0.03, 0.83 kg; P = 0.03) more on the low-fat

79 risk allele was 1.4 +/- 0.3 vs. 2.2 +/- 0.44 kg/m(2) in persons with fasting glucose levels below and

80 or 0.45 kg fresh strawberries) to a high-fat (50 g total fat) me

81 ighest 4-MEI concentrations (up to 466microg/kg) were observed in roasted barley, roasted malt and co

82 rbohydrate diet [mean group difference: 2.47 kg (95% CI: 0.20, 4.75 kg); P = 0.03].

83 -0.23 +/- 0.56 compared with -0.20 +/- 0.49 kg/m(2)).

84 kg) and lower volume of distribution (17.4mL/kg).Total drug elimination from the circulation after th

85 and achieved an average weight loss of 10.5 kg (10% of initial body weight).

86 sistance profile, low body mass index (<18.5 kg/m2), human immunodeficiency virus status, and study s

87 ght (>5 kg), and body mass index (BMI) (>3.5 kg/m(2)).

88 e system weighed only 5.9 kg (13 lbs) or 4.5 kg (10 lbs) without a controller and could hold up to 11

89 .1 years; mean body mass index, 27.9 +/- 5.5 kg/m(2); mean length of BE, 3.7 +/- 3.2 cm).

90 ontent and high molecular weight (up to 92.5 kg mol(-1) ).

91 arge effects on height (>2.4 cm), weight (>5 kg), and body mass index (BMI) (>3.5 kg/m(2)).

92 expected to confer a lifetime exposure of 5-kg/m2 higher BMI was associated with a lower risk of PD

93 erate (13%) PHA content can produce about 50 kg of alkenes per tonne of suspended solids treated, wit

94 At 50 kg in estimated weight, the extinct Siamogale melilutra

95 t concentrations varying between <LOQ (50mug/kg) and 9480mug/kg.

96 B 25microg.kg(-1) with a maximum of 53microg.kg(-1)).

97 O: 0.43 [95% confidence interval, 0.32-0.54] kg/m(2) per A-allele, P<0.001; BMI gene score: 1.05 [95%

98 m 259 Caucasian women at delivery (BMI 18-55 kg/m(2)).

99 3mg/kg for dehulled red lentils to 1630.5mg/kg for ruviotto beans.

100 A limit of quantification of 5microg.kg(-1) for both solid and liquid samples was achieved, e

101 range: 6.6-11.9 kg in Look AHEAD; 11.5-14.6 kg in DPP; P < 0.0001).

102 the yield table's data for Hungary, was 4.6 kg C/m(2) .

103 At harvest, 62.6 kg of nitrogen would be sequestered in mussel tissue and

104 For example, greater grip strength (per 6 kg) had an odds ratio (95% CI) of 0.85 (0.73-1.00) for i

105 an difference: -1.06 kg; 95% CI: -2.75, 0.63 kg; P = 0.22).

106 ile for oxamyl the LOQs were 2.9 and 0.67mug/kg, respectively.

107 values of imidacloprid were 0.47 and 2.6mug/kg in green beans and chili peppers, respectively, while

108 roductivity (PFPN) of the farmers were 336.7 kg ha(-1), 8131.8 kg ha(-1) and 24.2 kg kg(-1), respecti

109 N density was 577.0, 530.4, 513.2, and 336.7 kg/ha for tropical, subtropical, temperate, and boreal f

110 otal nucleated cells infused was 3.4 x 10(7)/kg.

111 body weight (-1.40 kg; 95% CI: -2.07, -0.74 kg).

112 Weight increased by 0.68 and 1.75 kg in the IN and RE groups, respectively (mean differenc

113 roup difference: 2.47 kg (95% CI: 0.20, 4.75 kg); P = 0.03].

114 nged from 64.5 to 77.7% and 18.1 to 1476.7mg/kg, respectively.

115 tolvaptan (-2.4 +/- 2.1 kg vs. -0.9 +/- 1.8 kg; p < 0.001).

116 years) and a median body mass index of 27.8 kg/m(2) (IQR, 26.0-33.1 kg/m(2)).

117 4 kg/m(2) [range, 24.7-48.1 kg/m(2)] vs 29.8 kg/m(2) [range, 22.9-44.0 kg/m(2)]) were not significant

118 ge, 48 years, 89% men, body mass index, 30.8 kg/m(2)), 86% completed the trial with good adherence.

119 , Cr(VI) is produced at a rate of 0.3 to 4.8 kg Cr(VI)/km(2)/yr and subsequently flushed from soil du

120 ; mean weight above prepregnancy weight, 7.8 kg; mean months post partum, 5.2 months) randomized to t

121 of the farmers were 336.7 kg ha(-1), 8131.8 kg ha(-1) and 24.2 kg kg(-1), respectively.

122 s lost a mean of 0.43 kg (95% CI: 0.03, 0.83 kg; P = 0.03) more on the low-fat and high-carbohydrate

123 ommended limit, and ranging from 2578+/-86mg/kg to 5063+/-230mg/kg of dry weight potato flesh.

124 ncreases in oak biomass resulted in only 1.9 kg C/m(2) increase over 41 years.

125 maintainers (mean difference range: 6.6-11.9 kg in Look AHEAD; 11.5-14.6 kg in DPP; P < 0.0001).

126 e at 12 years in nonsurgery group 1 was -2.9 kg (95% CI, -6.9 to 1.0; mean percent change, -2.0), and

127 ed BMI into categories of healthy (20.0-24.9 kg/m(2)), overweight (25.0-29.9 kg/m(2)), class I (mild)

128 y (20.0-24.9 kg/m(2)), overweight (25.0-29.9 kg/m(2)), class I (mild) obesity (30.0-34.9 kg/m(2)), an

129 ng water infiltration, exporting 0.01 to 3.9 kg Cr(VI)/km(2)/yr at concentrations ranging from 25 to

130 mean age 51.8 years and body mass index 31.9 kg/m(2) ), 66% were women.

131 kg/m(2)), class I (mild) obesity (30.0-34.9 kg/m(2)), and class II and III (severe) obesity (>/=35.0

132 The system weighed only 5.9 kg (13 lbs) or 4.5 kg (10 lbs) without a controller and

133 varying between <LOQ (50mug/kg) and 9480mug/kg.

134 eight over a period of about 12 months (0.99 kg, 95% credible interval [CrI] -0.09 to 0.28; moderate

135 ation (1000mg of DL-alpha-tocopheryl acetate/kg of basal diet) on physicochemical and fatty acid stab

136 s, typically at concentrations of 1-2 mug As kg(-1), primarily as the inorganic species arsenate.

137 Adding 400mg of TPB extract/kg of TTB did not exhibit any undesired effect on lactic

138 TTB enriched with 400mg of TPB extract/kg of TTB revealed the lowest peroxide values at all the

139 g/kg/d) in the lower-protein group vs 16.0 g/kg/d (15.1-16.9 g/kg/d) in the higher-protein group) (P

140 injections of ethyl carbamate (urethane, 1 g/kg body weight) were established and lung tumorigenesis

141 ups: mean (95% CI), 16.3 g/kg/d (15.4-17.1 g/kg/d) in the lower-protein group vs 16.0 g/kg/d (15.1-16

142 on (either by intraperitoneal injection, 2 g/kg, twice/day, for 7 days; or intermittent drinking 20%

143 higher-protein groups: mean (95% CI), 16.3 g/kg/d (15.4-17.1 g/kg/d) in the lower-protein group vs 16

144 Longer alcohol exposure (7 d x 2.5 g/kg, i.p.) restricted these increases to the dorsal stria

145 n increase in actual protein intake by 0.6 g/kg/d (0.4-0.7 g/kg/d) (P < .001).

146 tual protein intake by 0.6 g/kg/d (0.4-0.7 g/kg/d) (P < .001).

147 er-protein group vs 16.0 g/kg/d (15.1-16.9 g/kg/d) in the higher-protein group) (P = .70), despite an

148 AUC) (33mugh/mL) and high clearance (916mL/h/kg) and lower volume of distribution (17.4mL/kg).Total d

149 The mean (SD) IE count was 1325 (1093) IE/kg.

150 roups with baseline body mass index (BMI; in kg/m(2)) >/=30 and <30, respectively.These findings do n

151 s of variance.Three body mass index (BMI; in kg/m(2)) trajectory patterns were identified and labeled

152 SD age: 25 +/- 6 y; body mass index (BMI; in kg/m(2)): 23 +/- 2].

153 , being overweight [body mass index (BMI; in kg/m(2)): 25 to <30] is reportedly associated with a low

154 = 4), 100 (n = 4), 150 (n = 2), and 200 kBq/kg (n = 4) of (225)Ac-PSMA-617 were evaluated retrospect

155 years), weighing 14 to 34 kg (median, 18 kg) kg of whom 4 had occluded inferior vena cava or iliac ve

156 production was low ( approximately 0.87 kWh/kg H2O2) compared to previous studies using real wastewa

157 fter injection of (125)I-pentixafor (7.5 MBq/kg).

158 Weekly injections of 1 mg kg(-1) of mRNA into immunodeficient mice maintain trough

159 pendent once injection doses are above 15 mg kg(-1) : high dose expedited the renal excretion and sho

160 for aromatic amines in textiles (0.007-2 mg kg(-1)) were well below the limits legislated by the Eur

161 legislated by the European Union (EU) (30 mg kg(-1)) and those in urine and wastewater (0.004-1.5 mug

162 eline and after the administration of 0.5 mg kg(-1) oral D-amphetamine.

163 ritoneal injection of luseogliflozin (0.9 mg kg(-1)) did not change MAP, HR, RBF, or creatinine clear

164 Expansion cohorts were initiated at 3.0 mg/kg in patients with melanoma (n = 16) and renal cell car

165 he expansion cohort were treated with 1.0 mg/kg luspatercept; dose titration up to 1.75 mg/kg was all

166 e (0.5 mg/kg), or high dose ketamine (1.0 mg/kg) after induction of anaesthesia, before surgical inci

167 values and the prevalence of low TBI (<0 mg/kg) in preschool children (PSC) (age range: 6-59 mo) and

168 ient asymptomatic hyponatremia at the 1.0-mg/kg dose level.

169 , mavacoxib (4 mg/kg BW) and meloxicam (1 mg/kg BW) were determined following single oral (PO) and in

170 mab 2 mg/kg plus intravenous ipilimumab 1 mg/kg every 3 weeks for four doses, followed by intravenous

171 ty analysis set: three at dose level 1 (1 mg/kg), three at dose level 2 (3 mg/kg), six at dose level

172 trial) assessed four doses of avelumab (1 mg/kg, 3 mg/kg, 10 mg/kg, and 20 mg/kg), with dose-level co

173 essed as percentage (F%) of celecoxib (10 mg/kg BW), mavacoxib (4 mg/kg BW) and meloxicam (1 mg/kg BW

174 one [7%]) in three patients treated at 10 mg/kg dose level, and autoimmune disorder (one [5%]), incre

175 the IV infusion series of 30 mg/kg and 10 mg/kg doses, respectively.

176 , and immunological analysis, we chose 10 mg/kg every 2 weeks as the dose for further development and

177 tients were treated with pembrolizumab 10 mg/kg every 2 weeks for up to 24 months.

178 Durvalumab was administered at 10 mg/kg every 2 weeks or 1,500 mg every 4 weeks with either o

179 fined as a total TXA dose greater than 10 mg/kg for 50% of the operative duration.

180 imilar result was observed when BNN27 (10 mg/kg i.p.) was administered at the onset of diabetes, ever

181 randomly assigned (2:1) to ipilimumab 10 mg/kg or placebo every 3 weeks for up to four doses.

182 6% (29/52) and was similar between the 10 mg/kg Q2W and 10 and 20 mg/kg QW/Q2W cohorts.

183 d by 14 weeks of 5 mg/kg isoniazid and 10 mg/kg rifampicin per day.

184 nnabinoid receptor 2 antagonist AM630 (10 mg/kg) or inverse agonist JTE907 (3 mg/kg) during immunizat

185 DN-DISC1) mice were injected with THC (10 mg/kg) or vehicle for 10 days during mid-adolescence-equiva

186 evel 2 (3 mg/kg), six at dose level 3 (10 mg/kg), and six at dose level 4 (20 mg/kg).

187 r doses of avelumab (1 mg/kg, 3 mg/kg, 10 mg/kg, and 20 mg/kg), with dose-level cohort expansions to

188 were exacerbated by allopregnanolone (10 mg/kg, IP) and attenuated by progesterone (30 mg/kg, IP) in

189 tuzumab govitecan once weekly at 8 and 10 mg/kg, or two times per week at 4 and 6 mg/km on weeks 1 an

190 ce and web response system to receive 100 mg/kg opicinumab intravenously or placebo once every 4 week

191 e (n = 48; 7 consecutive cohorts, 0.3-100 mg/kg) or 4 weekly infusions (n = 16; 2 consecutive cohorts

192 cortex; furthermore, finasteride (10-100 mg/kg, IP) dose-dependently ameliorated PPI deficits, hyper

193 1.3 mug/dL and 1.5 mug/dL in BLL per 1000 mg/kg Pb in soil were observed for this study area using to

194 every 21 days with either bevacizumab 15 mg/kg every 21 days or 5 million units of IFN-alpha-2b thre

195 Caffeine (5, 10, or 15 mg/kg), a nonspecific adenosine receptor antagonist, dose-d

196 eated with saline, phencyclidine (PCP, 15 mg/kg/d by osmotic minipump), or PCP+glycine (16% by weight

197 ty against ZIKV, we predict a dose of 150 mg/kg given twice a day initiated at the time of infection

198 ubcutaneous administration of RG-101 at 2 mg/kg (n = 14) or 4 mg/kg (n = 14) or received a placebo (n

199 , followed by intravenous pembrolizumab 2 mg/kg every 3 weeks for up to 2 years or disease progressio

200 ive doses of rovalpituzumab tesirine (0.2 mg/kg or 0.4 mg/kg every 3 weeks or 0.3 mg/kg or 0.4 mg/kg

201 ents received intravenous pembrolizumab 2 mg/kg plus intravenous ipilimumab 1 mg/kg every 3 weeks for

202 eeks later, they were subjected to LPS (2 mg/kg) or sepsis by cecal ligation and puncture (CLP).

203 f a single ketamine infusion (saline, 0.2 mg/kg, 0.5 mg/kg).

204 s an acceptable toxicity profile up to 20 mg/kg and the maximum tolerated dose was not reached.

205 %]) in three patients who received the 20 mg/kg dose.

206 ar between the 10 mg/kg Q2W and 10 and 20 mg/kg QW/Q2W cohorts.

207 lumab (1 mg/kg, 3 mg/kg, 10 mg/kg, and 20 mg/kg), with dose-level cohort expansions to provide additi

208 3 (10 mg/kg), and six at dose level 4 (20 mg/kg).

209 given with oral 5 mg/kg isoniazid and 25 mg/kg pyrazinamide per day for 12 weeks, followed by 14 wee

210 ificantly attenuated by carbenoxolone (25 mg/kg).

211 -26) in patients treated with nivolumab 3 mg/kg in the dose-expansion phase and 15% (95% CI 6-28) in

212 2 mg/kg or 0.4 mg/kg every 3 weeks or 0.3 mg/kg or 0.4 mg/kg every 6 weeks), 11 (18%) of 60 assessabl

213 In wild-type (WT) mice, LY2828360 (3 mg/kg per day i.p. x 12 days) suppressed chemotherapy-induc

214 0 (10 mg/kg) or inverse agonist JTE907 (3 mg/kg) during immunization heightens the intensity and brea

215 vel 1 (1 mg/kg), three at dose level 2 (3 mg/kg), six at dose level 3 (10 mg/kg), and six at dose lev

216 l challenge with unlabeled yohimbine (0.3 mg/kg).

217 sessed four doses of avelumab (1 mg/kg, 3 mg/kg, 10 mg/kg, and 20 mg/kg), with dose-level cohort expa

218 1 hour after the IV infusion series of 30 mg/kg and 10 mg/kg doses, respectively.

219 T5 (n = 12 each) received three 10 or 30 mg/kg IV VRC01 doses every 8 weeks, respectively.

220 pioid receptor (KOR) antagonist JDTic (30 mg/kg, i.p.) before CSDS reduced stress effects on both sle

221 g, IP) and attenuated by progesterone (30 mg/kg, IP) in SD-subjected, but not control rats.

222 MAT1A-KO mice were also given SAMe (30 mg/kg/day for 8 weeks); liver samples were collected and an

223 Steady-state concentrations (34 mg/kg) and BAF values (0.05) obtained for the snail directl

224 ration of RG-101 at 2 mg/kg (n = 14) or 4 mg/kg (n = 14) or received a placebo (n = 2/dosing group).

225 of celecoxib (10 mg/kg BW), mavacoxib (4 mg/kg BW) and meloxicam (1 mg/kg BW) were determined follow

226 rovalpituzumab tesirine (0.2 mg/kg or 0.4 mg/kg every 3 weeks or 0.3 mg/kg or 0.4 mg/kg every 6 weeks

227 4 mg/kg every 3 weeks or 0.3 mg/kg or 0.4 mg/kg every 6 weeks), 11 (18%) of 60 assessable patients ha

228 ed, all in patients in the adalimumab 0.4 mg/kg group, and were not judged to be related to study dru

229 vascular-targeted photodynamic therapy (4 mg/kg padeliporfin intravenously over 10 min and optical fi

230 ve [2%]) in the trastuzumab emtansine 2.4 mg/kg weekly group compared with pneumonia (four [4%]), feb

231 Patients received 5 mg/kg belatacept every 2 weeks, and the dosing interval was

232 y for 12 weeks, followed by 14 weeks of 5 mg/kg isoniazid and 10 mg/kg rifampicin per day.

233 imental treatments were given with oral 5 mg/kg isoniazid and 25 mg/kg pyrazinamide per day for 12 we

234 ntraperitoneally daily for 14 days at 0.5 mg/kg or 2.5 mg/kg.

235 effects between intravenous ketamine (0.5 mg/kg over 40 min) and placebo (normal saline) on social ph

236 ring hydroxyurea to placebo at 20 +/- 2.5 mg/kg per day for 12 months.

237 twice per day for 7 days, followed by 0.5 mg/kg per day for 3 days).

238 to receive placebo or hydrocortisone (0.5 mg/kg twice per day for 7 days, followed by 0.5 mg/kg per d

239 o (normal saline), low-dose ketamine (0.5 mg/kg), or high dose ketamine (1.0 mg/kg) after induction o

240 ing intravenous infusion of ketamine (0.5 mg/kg).

241 ketamine infusion (saline, 0.2 mg/kg, 0.5 mg/kg).

242 lly daily for 14 days at 0.5 mg/kg or 2.5 mg/kg.

243 , when compound 23 was administered at 50 mg/kg via single dose ip.

244 Systemic treatment of rats with 6 mg/kg 6c either simultaneously or 18 h prior to systemic AM

245 min; trastuzumab 8 mg/kg loading dose, 6 mg/kg maintenance doses) plus pertuzumab [same dosing as in

246 lus pertuzumab (trastuzumab emtansine 3.6 mg/kg; pertuzumab 840 mg loading dose, 420 mg maintenance d

247 (n = 16; 2 consecutive cohorts, 30 and 60 mg/kg per infusion) of TNT009 or placebo.

248 -blocking potential of 4 weekly doses (60 mg/kg) of the anti-C1s antibody BIVV009 in complement-media

249 ce received vehicle or BACE inhibitor (60 mg/kg) starting at 7 wk of age.

250 803-mts), starting from 4 hours after 600 mg/kg dose of APAP, resulted in early initiation of liver r

251 g luspatercept; dose titration up to 1.75 mg/kg was allowed, and patients could be treated with luspa

252 n contrast to a single-dose treatment (75 mg/kg/day), repeated doses of peramivir rescued BALB scid m

253 n-time curve 6 mg/mL x min; trastuzumab 8 mg/kg loading dose, 6 mg/kg maintenance doses) plus pertuzu

254 nated cabbage (tissue concentration of 86 mg/kg; BAF of 0.36).

255 Lipo-15-epi-LXA4 or 15-epi-LXA4 (1 microg/kg/day) was injected 3 hours post-MI for (d)1 or continu

256 ments, even at routine MDA doses (150 microg/kg) and frequencies (annual).

257 /-2.3 versus 10.0+/-3.4 and12.9+/-4.0 mL/min.kg; P<0.0001), higher biventricular filling pressures wi

258 after rapid infusion of warmed saline (15 mL kg(-1) , approximately 7 min).

259 confidence interval [CI], 1.13-2.28 per 1-ml/kg PBW decrease in Vt; P = 0.008).

260 verage oxygen consumption was 1.1 +/- 0.2 mL/kg per minute.

261 gen consumption, 24+/-1.3 versus 31+/-1.3 mL/kg/min, P<0.001; increased VE/Vco2 slope, 31+/-1 versus

262 sthetized and mechanically ventilated, 40 mL/kg of blood was removed yielding marked hypotension and

263 A minimum hourly urine output of 0.5 mL/kg is a key target guiding perioperative fluid therapy.

264 and after reducing tidal volume back to 6 mL/kg predicted body weight.

265 6.6) mL/kg per minute to 16.1 (13.2-18.6) mL/kg per minute (P=0.009 for within-group changes), wherea

266 ovement in peak Vo2 from 14.5 (10.5-16.6) mL/kg per minute to 16.1 (13.2-18.6) mL/kg per minute (P=0.

267 st was performed at tidal volumes 6 and 8 mL/kg predicted body weight and after reducing tidal volume

268 after increasing tidal volume from 6 to 8 mL/kg predicted body weight predicted fluid responsiveness

269 The effects of CP 55 940 (1.0-10 mug/kg, i.v.) and THC (3.0-300 mug/kg, i.v.) on food-maintai

270 uman health cancer screening value of 12 mug/kg in 48% of the national sampled population of river km

271 min at 80 mug/kg/d and then 60 min at 30 mug/kg/d) or terlipressin (single 2-mg i.v. bolus), and the

272 d that the intake of nicotine (15 and 30 mug/kg/inf) varied among these strains by 33.7-56.6-fold.

273 0 (1.0-10 mug/kg, i.v.) and THC (3.0-300 mug/kg, i.v.) on food-maintained responding and body tempera

274 ere assigned with 120 +/- 8 and 36 +/- 4 mug/kg, respectively.

275 r occupancy by eliprodil occurred at 1.5 mug/kg.

276 ers had a national weighted mean of 32.7 mug/kg and a maximum concentration of 857 mug/kg, and exceed

277 venous (i.v.) infusion (for 60 min at 80 mug/kg/d and then 60 min at 30 mug/kg/d) or terlipressin (si

278 ug/kg and a maximum concentration of 857 mug/kg, and exceeded the human health cancer screening value

279 aride (LPS) administration at a dose of 2 ng/kg of body weight on motivation in 21 healthy human subj

280 to rats of a single small dose of Hi1a (2 ng/kg) up to 8 h after stroke induction by occlusion of the

281 cotreatment with the alphaAnalogue (50 nmol.kg(-1).d(-1), SC, at a dose selected for lack of long-te

282 -136088 specific binding were 73 +/- 30 nmol/kg and 28 +/- 12 nM, respectively.

283 x-adjusted hazard ratio 1.05 [1.04-1.06] per kg/m(2), P<0.001).

284 cell dose of more than 21 x 10(7) cells per kg compared with 21 x 10(7) cells per kg or less (HR 1.4

285 ls per kg compared with 21 x 10(7) cells per kg or less (HR 1.47, 1.11-1.95, p=0.0076), and transplan

286 mounts wasted, while the specific impact per kg is largest for beef.

287 hile 1.0, 0.10, 3.3, 0.33, 0.88, and 0.09 pg kg bw(-1) day(-1) were found in personal air for PFHxA,

288 1.7, 0.17, 5.7, 0.57, 1.8, 0.18, and 2.3 pg kg bw(-1) day(-1) were obtained in residential indoor ai

289 kg bw(-1) day(-1)) and personal air (3.3 pg kg bw(-1) day(-1)) were both around 5 orders of magnitud

290 intakes from residential indoor air (5.7 pg kg bw(-1) day(-1)) and personal air (3.3 pg kg bw(-1) da

291 concentrations (43 pg/kg bw/d versus 130 pg/kg bw/d).

292 ther than personal air concentrations (43 pg/kg bw/d versus 130 pg/kg bw/d).

293 lence is as high as 44.1 and 47.4mmol Trolox/kg for the yellow and red-violet varieties analyzed resp

294 141 Wh kg(-1) , power densities of 20 600 W kg(-1) , and output voltage of 2.4 V can be delivered du

295 st cancer with body mass index (BMI; weight (kg)/height (m)2) at age 18-21 years, BMI at baseline, an

296 ht, weight, or body mass index (BMI; weight (kg)/height (m)2) measured concurrently with the adiposit

297 l prepregnancy body mass index (BMI; weight (kg)/height (m)2), gestational weight gain (GWG), birth s

298 Energy densities of 141 Wh kg(-1) , power densities of 20 600 W kg(-1) , and output

299 higher energy density ( approximately 400 Wh kg(-1)) than all other reported rechargeable magnesium b

300 s record-high energy densities up to 200 Wh/(kg of total electrode mass) for >1,000 cycles at approxi